PSC Collaboration Study- PROGRESS

C
Craig Lammert, MD

Primary Investigator

Enrolling By Invitation
18 years - 100 years
All
Phase N/A
2 Locations

Brief description of study

Primary Sclerosing Cholangitis (PSC) is a chronic liver disease that lacks treatment options short of liver transplantation. This is secondary to rarity of the disease and poor understanding of the disease pathogenesis. We are participating in a multi-center study collecting PSC patients clinical and biological information along with genetic analysis in hope to discover potential gene candidates implicated in PSC.

Detailed description of study

Primary Sclerosing Cholangitis (PSC) is a chronic liver disease that lacks treatment options short of liver transplantation. This is secondary to rarity of the disease and poor understanding of the disease pathogenesis. We are participating in a multi-center study collecting PSC patients clinical and biological information along with genetic analysis in hope to discover potential gene candidates implicated in PSC.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: PSC, Primary Sclerosing Cholangitis
  • Age: 18 years - 100 years
  • Gender: All


Updated on 01 Aug 2024. Study ID: 1011004220
Please visit our main page to search for other studies you may be interested in. If you need help finding a study or have any questions, please contact us at inhealth@iu.edu

Interested in the study?

This study is accepting only persons who receive care at a certain clinic or doctor or who are part of an invited group. Questions about this study can be directed to the study team listed in the description or contact your doctor to see if you are eligible.

Accepting Referrals by Invitation Only